Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Biotechnology Portfolio

+ Add to Watchlist

FBIOX:US

235.85 USD 0.81 0.34%

As of 09:29:30 ET on 01/30/2015.

Snapshot for Fidelity Select Biotechnology Portfolio (FBIOX)

Year To Date: +6.59% 3-Month: +11.82% 3-Year: +42.49% 52-Week Range: 154.82 - 239.90
1-Month: +6.59% 1-Year: +27.26% 5-Year: +33.22% Beta vs MXWO: 1.06

Mutual Fund Chart for FBIOX

No chart data available.
  • FBIOX:US 235.85
  • 1M
  • 1Y
Interactive FBIOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBIOX

Fidelity Select Biotechnology Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-16-1985 Telephone: 1-800-544-6666
Managers: RAJIV KAUL
Web Site: www.fidelity.com

Fundamentals for FBIOX

NAV (on 2015-01-30) 235.85
Assets (M) (on 2014-12-31) 10,924.37
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBIOX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-05) 23.84
Dividend Yield (ttm) 10.11

Fees & Expenses for FBIOX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.75

Top Fund Holdings for FBIOX

Filing Date: 11/30/2014
Name Position Value % of Total
Gilead Sciences Inc 9,966,721 999,861,451 9.566%
Vertex Pharmaceuticals Inc 4,835,194 569,972,669 5.453%
Celgene Corp 4,958,551 563,737,663 5.393%
Alexion Pharmaceuticals Inc 2,438,569 475,277,098 4.547%
Regeneron Pharmaceuticals Inc 1,114,585 463,789,964 4.437%
Receptos Inc 2,237,240 302,698,572 2.896%
Medivation Inc 2,549,127 295,418,328 2.826%
Puma Biotechnology Inc 1,150,625 261,214,888 2.499%
BioMarin Pharmaceutical Inc 2,703,665 242,572,824 2.321%
Incyte Corp 2,634,125 199,008,144 1.904%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil